Cargando…
Editing cholesterol out of the blood
In patients with high cholesterol and at risk of cardiovascular disease, inhibitors of PCSK9 are useful in lowering lipid levels but must be dosed regularly. A recent study in Nature by Munsunuru and colleagues explores the possibility of permanently disrupting PCSK9 expression via in vivo CRISPR ge...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037316/ https://www.ncbi.nlm.nih.gov/pubmed/35602209 http://dx.doi.org/10.1038/s43856-021-00011-5 |
_version_ | 1784693709339623424 |
---|---|
author | Abbott, Ben |
author_facet | Abbott, Ben |
author_sort | Abbott, Ben |
collection | PubMed |
description | In patients with high cholesterol and at risk of cardiovascular disease, inhibitors of PCSK9 are useful in lowering lipid levels but must be dosed regularly. A recent study in Nature by Munsunuru and colleagues explores the possibility of permanently disrupting PCSK9 expression via in vivo CRISPR gene editing in non-human primates, with long-lasting reductions in LDL cholesterol. |
format | Online Article Text |
id | pubmed-9037316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90373162022-05-20 Editing cholesterol out of the blood Abbott, Ben Commun Med (Lond) Research Highlight In patients with high cholesterol and at risk of cardiovascular disease, inhibitors of PCSK9 are useful in lowering lipid levels but must be dosed regularly. A recent study in Nature by Munsunuru and colleagues explores the possibility of permanently disrupting PCSK9 expression via in vivo CRISPR gene editing in non-human primates, with long-lasting reductions in LDL cholesterol. Nature Publishing Group UK 2021-06-30 /pmc/articles/PMC9037316/ /pubmed/35602209 http://dx.doi.org/10.1038/s43856-021-00011-5 Text en © Springer Nature Limited 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Highlight Abbott, Ben Editing cholesterol out of the blood |
title | Editing cholesterol out of the blood |
title_full | Editing cholesterol out of the blood |
title_fullStr | Editing cholesterol out of the blood |
title_full_unstemmed | Editing cholesterol out of the blood |
title_short | Editing cholesterol out of the blood |
title_sort | editing cholesterol out of the blood |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037316/ https://www.ncbi.nlm.nih.gov/pubmed/35602209 http://dx.doi.org/10.1038/s43856-021-00011-5 |
work_keys_str_mv | AT abbottben editingcholesteroloutoftheblood |